Enhancements    

EARLY DETECTION AND THERAPEUTIC TARGETING OF OVARIAN CANCER USING A TESTIS-SPECIFIC PROTEIN DOPPEL

EARLY DETECTION AND THERAPEUTIC TARGETING OF OVARIAN CANCER USING A TESTIS-SPECIFIC PROTEIN DOPPEL
PI: Taslim Al-Hilal
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
Pharmaceutical Sciences
Amount awarded: $45,000

This research evaluates a biomarker that may be instrumental in advancing ovarian cancer and develops a therapeutic strategy to counter its effect.

Posting date: Mon, 03/14/2022

Award start date: Thu, 03/03/2022
Award end date: Wed, 11/30/2022